Specialty Pharmacy

Experimental drug could may lead to new treatments for AML, lung cancer, brain cancer, and melanoma.

Scoring can optimize limited resources to target specific patients.

Growing out-of-pockets costs associated with reduced utilization of specialty medications.

Top news of the day across the health care landscape.

Top articles of the week on Specialty Pharmacy Times.

Only 20% of lung cancer patients show a response to current immunotherapeutic antibodies.

Guide RNA shows promise eliminating HIV from the DNA of CD4 T cells.

Experimental drug bococizumab could fill the unmet needs of patients at risk for cardiovascular disease.

The combination drug Genvoya offers minor benefits in pretreated women and no benefit in pretreated men with HIV.

Study finds that manufacturers need to develop a new approach to engaging oncologists.

Rebrand to focus on enhanced collaboration with member pharmacies, manufacturers, payers and other industry stakeholders to develop complete solutions for specialty pharmaceuticals.

PCSK9 inhibitor shows promise for statin-intolerant patients with muscle-related side effects.

Humira shows promise for pediatric Crohn’s disease patients who are intolerant to or had an inadequate response to conventional therapy.

People from poor or middle-income households with conditions such as diabetes or asthma face greater risk for serious mental illness.

Many physicians prescribe multi-drug tuberculosis regimens in patients with HIV as a precaution.

Tuberculosis is difficult to detect in patients with HIV.

Top stories of the day from across the health care landscape.

Pharmacists can also help find HIV assistance programs for patients who need help financially.

Tofacitinib is an oral Janus kinase inhibitor that improves the signs and symptoms of psoriatic arthritis.

Automated pharmacies are confronted with growing demands for prescription drug fills.

Biosimilar infliximab-dyyb (Inflectra) treats a variety of autoimmune diseases.

Biosimilar infliximab-dyyb (Inflectra) treats a variety of autoimmune diseases, including Crohn’s disease, rheumatoid arthritis, and psoriatic arthritis.

SAMMSON gene thought to play an important role in the etiology of melanoma.

Combining drug trametinib with a superagonist can stimulate activity while preserving the cancer-blocking effects of the treatment.

People with difficulty repairing damaged DNA develop diabetes more rapidly when beta cells are met with cellular stress.

Plant produces compounds that treat cancer, arrhythmia, and other medical problems.

Descovy contains 2 HIV nucleoside analog reverse transcriptase inhibitors, emtricitabine, and tenofovir alafenamide.

Descovy is not a complete regimen and must be used in combination with other antiretroviral agents for the treatment of HIV.